Category - Any -Programs & products-Lacutamab-IPH4502-Monalizumab-ANKET-IPH5201-IPH5301Financials and Corporate Year - Any -202620252024202320222021202020192018201720162015201420132012201120102009 Apply Financial results for 2008 February 27, 2009 Milestone payment in IPH 24 project developed in collaboration with Novo Nordisk A/S February 12, 2009 Operating revenue of 12.9 million Euros for the year 2008 February 6, 2009 Pagination First page « First Previous page ‹ Previous … Page 55 Page 56 Page 57 Page 58 Page 59 Page 60 Page 61 Page 62 Current page 63
Milestone payment in IPH 24 project developed in collaboration with Novo Nordisk A/S February 12, 2009
